Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2000
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000US6074838 Zearalenone detoxification compositions and methods
06/13/2000US6074836 Method of marking eukaryotic cells
06/13/2000US6074829 Modified two-hybrid assay using dna-binding domains as detection domains to effectively eliminate false positives
06/13/2000US6074826 Nucleic acid amplification oligonucleotides and probes to Lyme disease associated Borrelia
06/13/2000US6074821 CDNA for human methylenetetrahydrofolate reductase
06/13/2000US6074820 Detection and differentiation of mycobacterium tuberculosis complex bacteria by direct variant repeat oligotyping
06/13/2000US6074818 Fingerprinting of nucleic acids, products and methods
06/13/2000US6074817 Recombinant mono and poly antigens to detect cytomegalovirus-specific IgM in human sera by enzyme immunoassay
06/13/2000US6074816 Oligonucleotides which hybridize to genome of non a and non b hepatitis virus; for probes and primers
06/13/2000US6074649 Recombinant composition containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
06/13/2000US6074646 Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies
06/13/2000US6074642 Reduce cell lysing ability of biological complement present in blood
06/13/2000US6074639 Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins
06/13/2000CA2159079C Methods and dna expression systems for over-expression of proteins in host cells
06/13/2000CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
06/13/2000CA2095624C Method of targeting dna
06/13/2000CA2079105C Hepatitis c virus protease
06/13/2000CA2048450C Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
06/13/2000CA1341026C Il-1 inhibitors process for producing il-1 inhibitors and for using such inhibitors in therapy
06/13/2000CA1341022C Prepro-lhrh c-terminal peptide
06/13/2000CA1341021C Hepatitis surface antigen particle vaccine
06/09/2000CA2290711A1 Methods for diagnosing a form of ataxia and compounds for use in the method
06/09/2000CA2289951A1 Processes for preparation of marek's disease virus using continuous avian cell lines
06/09/2000CA2286312A1 Peptide fragments derived from cwpm23, a protein involved in freezing resistance of winter wheat
06/08/2000WO2000033161A2 Methods to reduce variance in treatment studies using genotyping
06/08/2000WO2000033084A2 Arrays of organic compounds attached to surfaces
06/08/2000WO2000033078A1 Porous coatings bearing ligand arrays
06/08/2000WO2000033068A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
06/08/2000WO2000033067A1 Method for diagnosing neoplasia
06/08/2000WO2000032825A2 Development of anti-microbial agents based on bacteriophage genomics
06/08/2000WO2000032824A2 Length determination of nucleic acid repeat sequences by discontinuous primer extension
06/08/2000WO2000032823A1 Dna-protein fusions and uses thereof
06/08/2000WO2000032822A1 Methods for introducing heterologous cells into fish
06/08/2000WO2000032821A1 Methods for making recombinant cells
06/08/2000WO2000032818A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression
06/08/2000WO2000032817A1 Antisense modulation of g-alpha-16 expression
06/08/2000WO2000032816A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000WO2000032815A1 Molecular conjugate to promote homologous genetic recombination
06/08/2000WO2000032814A2 Methods for producing selected interstrand cross-links in nucleic acids and applications thereof
06/08/2000WO2000032813A1 Method and system for detecting oligonucleotides in a sample
06/08/2000WO2000032812A1 Method for separating nucleic acids into populations
06/08/2000WO2000032809A2 Cloning and copying on surfaces
06/08/2000WO2000032803A2 Novel nucleic acid transferring agents, compositions containing them and uses
06/08/2000WO2000032802A1 Hiv vaccine
06/08/2000WO2000032801A1 Manganese superoxide dismutase regulatory elements and uses thereof
06/08/2000WO2000032800A1 Artificial matrix attachment region for increasing expression of genes introduced in plant cells
06/08/2000WO2000032799A1 Methods for transforming plastids
06/08/2000WO2000032798A1 Xylanase promoter from thermomyces lanuginosus
06/08/2000WO2000032797A1 Transformed thermomyces lanuginosus
06/08/2000WO2000032796A2 Kinetoplastid protein expression system
06/08/2000WO2000032795A1 Dna encoding fusion proteins which are specifically cleavable by copper (ii) ions
06/08/2000WO2000032794A2 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032793A2 Plant cell derived diacylglycerol acyltransferases
06/08/2000WO2000032792A2 Plant 1-deoxy-d-xylulose 5-phosphate synthase
06/08/2000WO2000032791A2 Plan lecithin:cholesterol acyltransferases
06/08/2000WO2000032790A2 Membrane-bound desaturases
06/08/2000WO2000032789A1 Fruit flavour related genes and use thereof
06/08/2000WO2000032788A2 Method for regulating carotenoid biosynthesis in marigolds
06/08/2000WO2000032786A1 gp120 MUTANTS AND BIOLOGICAL APPLICATIONS
06/08/2000WO2000032785A1 Isolation and characterization of a n. crassa silencing gene and uses thereof
06/08/2000WO2000032784A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032783A1 Plant transcription factors
06/08/2000WO2000032782A2 Plant transcription factors
06/08/2000WO2000032781A1 A sulfur metabolizing gene from the roots of onion
06/08/2000WO2000032780A1 Control of flowering
06/08/2000WO2000032779A1 Nucleic acids and polypeptides of d. melanogaster insulin-like genes and uses thereof
06/08/2000WO2000032778A2 Methods and compositions for inhibiting neoplastic cell growth
06/08/2000WO2000032777A2 Scorpion toxins
06/08/2000WO2000032776A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
06/08/2000WO2000032775A1 Pth1r and pth3r receptors
06/08/2000WO2000032774A1 12216 receptor, a g-protein coupled receptor
06/08/2000WO2000032773A1 Compositions and methods for increasing bone mineralization
06/08/2000WO2000032772A2 Erythropoietic compounds
06/08/2000WO2000032771A1 Pth1r and pth3r receptors, methods and uses thereof
06/08/2000WO2000032770A1 Novel tumor antigen protein art-1 and tumor antigen peptide thereof
06/08/2000WO2000032769A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
06/08/2000WO2000032768A1 Polypeptides capable of interacting with the human topoisomerase iii alpha
06/08/2000WO2000032767A1 RECOMBINANT SOLUBLE Fc RECEPTORS
06/08/2000WO2000032766A1 Human vanilloid receptors and their uses
06/08/2000WO2000032765A2 Ribozyme therapy for the treatment and/or prevention of restenosis
06/08/2000WO2000032764A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000WO2000032763A1 METHOD FOR SYNTHESIZING cDNA
06/08/2000WO2000032762A1 Magnetic particles for purifying nucleic acids
06/08/2000WO2000032761A1 Ethylene-response-factor1 (erf1) in plants
06/08/2000WO2000032760A1 Method of increasing growth and yield in plants
06/08/2000WO2000032757A2 Plant vitamin e biosynthetic enzymes
06/08/2000WO2000032754A1 An improved method for the production and purification of adenoviral vectors
06/08/2000WO2000032752A1 Psca: prostate stem cell antigen and uses thereof
06/08/2000WO2000032750A1 Transgenic circulating endothelial cells
06/08/2000WO2000032748A1 Gene networks for control of gene expression
06/08/2000WO2000032745A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000WO2000032634A1 Humanized antibodies to gamma-interferon
06/08/2000WO2000032631A2 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000WO2000032630A2 Nucleic acids and polypeptides derived from activated eosinophil cells and use thereof
06/08/2000WO2000032628A1 ReL1A BINDING INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
06/08/2000WO2000032627A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000WO2000032624A2 Uncoupling protein 5 - ucp5
06/08/2000WO2000032307A1 Preparation of multiwall polymeric microcapsules from hydrophilic polymers
06/08/2000WO2000032233A2 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
1 ... 3232 3233 3234 3235 3236 3237 3238 3239 3240 3241 3242 3243 3244 3245 3246 3247 3248 3249 3250 3251 3252 ... 4023